egypt's
assessment of need
EGYPT
Within Egypt, cardiovascular disease is by far the leading cause of death out of all non-communicable diseases, responsible for deaths in 2016 alone. Risk factors associated with cardiovascular disease continue to rise at an alarming rate. Rheumatic heart diseases are still responsible for approximately 2,000 deaths per year and of the 18,000 babies born with congenital heart disease each year, 5,000 die due to the lack of proper facilities.
Demand Constraints in Egypt
The availability of medical treatment is not sufficient to meet regional demand, resulting in hundreds of thousands of deaths that could have been avoided if suitable facilities and efficient personnel had been available.
Our aspiration is to scale up operations to meet the significant, growing demand for cardiovascular treatment by those who need it most, integrating treatment, research, and talent development in a way that currently does not exist in the region.
With the establishment of the Magdi Yacoub Global Heart Centre in Cairo, we will be able to triple the service and the amount of hearts saved, all free-of-charge and with the latest technology and technique in cardiovascular medical care. MYGHC - Cairo will give us the possibility to treat 12,000 patients, in contrast to 4,000 currently, and save more than three times as many lives.
EXECUTIVE SUMMARY
The current facility in Aswan has been stretched beyond its capacity and is unable to meet the needs and demands for cardiovascular treatment within its current resources. Therefore, to improve access to care and meet the demand for cardiac care within Egypt and the region on a broader scale, the Board of Trustees of the Magdi Yacoub Heart Foundation took the decision to develop the Magdi Yacoub Global Heart Centre (MYGHC), located in Cairo. Through the new centre we aim to continue and build on the Aswan Heart Centre’s legacy of excellence, whilst tripling the scale of our operations and capacity. With a project of this magnitude, we will have an even greater impact and be able to reach and help those who need it the most.
While the main beneficiaries of this new facility will be Egyptians, the new centre will also be able to accommodate some more of the complex cases from the MENA region, GCC and Africa. In addition to improving access to quality care, the new centre will also continue integrating research, innovation, and training on a much bigger scope, in a way that is unprecedented in the region. An integral part of the strategy is to expand training and continuous education for young healthcare professionals and scientists from Egypt and MENA, GCC and Africa, and to become a regional focal point for cardiovascular research and innovation.
our
vision
Expand access to world-class treatment
Our objective is to meet the increasing demand for cardiovascular care by expanding the size of our facility to be able to:
• Accommodate up to 120,000 outpatients annually
• Treat up to 12,000 patients annually
This would constitute a three-fold increase of our current capacity in Aswan, making the total activity quadruple what it is today.
We particularly look forward to increasing our capacity to treat neonates with congenital heart disease. If treated at our centre, a child has a 95% chance of living a normal life.
◦ Accommodate almost four times as many outpatients
◦ Treat more than three times as many patients in need from Egypt and the region
◦ Save more than three times as many lives
We hope, specifically, to be able to enhance the type of care that we provide to new-borns with congenital heart disease. Currently, we are able to treat less than half of all such cases. If treated at our centre, a child has a 95% chance of living a normal life. We will continue to endeavour to reduce the mortality rates and hence improve the 95% survival rate.
In addition to expanding our facilities, we plan to build a dedicated facility for tele-medicine to enhance our reach to support patients in more remote areas of Africa.
• Triple the number of training graduates
Saving lives is not only about increasing the capacity of our facilities; we also need qualified staff to provide care both at the Magdi Yacoub Global Aswan Heart Centre – Cairo and more broadly throughout the region. Therefore, we have a goal to expand our training program to train ~1,750 healthcare professionals and scientists annually (compared to 550 today), not only from Egypt, but from the region more broadly while ensuring the same level of quality we provide today.
• Develop an advanced scientific research centre
We aspire to become a centre for innovation in heart-related medical research, with the objective of reducing the prevalence of cardiovascular disease in some of the poorest areas of Africa by developing advanced treatments for complex diseases. Research centre will cover among others congenital heart diseases, precision medicine topic and diseases specific to the developing world (e.g. rheumatic diseases). This research will benefit from exposure to the large number of cases we expect to treat, covering cardiovascular disease specific to the developing world as well (e.g., rheumatic diseases). We also plan to create a broader hub for talented scientists and doctors by building a convention centre to host global medical conferences.
Triple the number of training graduates
Saving lives is not only about increasing the capacity of our facilities; we also need qualified staff to provide care both at the MYGHC in Cairo and more broadly throughout the country, and even the region. Therefore, we have a goal to expand our training program to train ~1,750 healthcare professionals and scientists annually (compared to 550 today), not only from Egypt, but from the region more broadly while ensuring the same level of quality and professionalism we provide today.
Develop an advanced scientific research centre
We aspire to become a centre for innovation in cardiac medical research, with the objective of reducing the prevalence of cardiovascular disease in Egypt, and some of the poorest areas of Africa by developing advanced treatments for complex diseases. Our Research centre will cover, among others, congenital heart diseases, precision medicine topics and diseases specific to the developing world (e.g. rheumatic diseases). This research will benefit from exposure to the large number of cases we expect to treat every year (~12,000). We also plan to create a broader hub for talented scientists and doctors by building a convention centre to host global medical conferences.
check our
facilities
The MYGHC will be built on a land area of 35 acres in 6th of October City. The hospital is built on 27 acres, the remaining 8 acres are for future extensions. The design of Foster and Partners and Dar Al-Handasah Company aims to create an environmentally friendly center, healing-enhanced, stress-free for working and learning, patient- and user-friendly.
The MYGHC in Cairo will include the following:
◦ 300 beds, enabling us to treat up to 12,000 patients each year
◦ 40% of bed capacity to be reserved for intensive care and coronary high-dependency units, the remaining 60% will be allocated to inpatients
◦ An integrated central hub housing five operating theatres and five catheterization laboratories, including a hybrid operating room
◦ A diagnostic imaging centre, equipped with the latest imaging technologies
◦ An outpatient department including 35 outpatient clinics for adults and paediatrics, which will allow us to receive more than 80,000 outpatients annually
◦ An emergency department
◦ A fully equipped integrated scientific research and innovation hub
◦ Administration offices
• Scientific research centre
The complex will include an integrated scientific research centre, equipped with the latest research technologies.
Environmentally efficient and friend
Healing-enhanced
Stress-free for working and learning
Patient- and user-friendly
THE HOSPITAL
We plan to build a new cardiac hospital with the following components:
- 300 beds capable of accommodating 150 adults and 150 paediatric patients, in line with current demand
- 40% of bed capacity reserved for intensive care and coronary high-dependency units
- Integrated central hub housing five operating theatres and five catheterization laboratories, including a hybrid operating room with a state-of-the-art imaging and diagnostic centre including nuclear imaging
Residential Buildings
- 1,200 residential units for staff and patient’s relatives
Scientific research centre
The complex will include an integrated scientific research centre, equipped with the latest research technologies.In addition, we will build a convention centre that can accommodate up to 700 delegates, with a state-of-the-art electronic library and tele-medicine facility.
check our
Goals
Our goal is to meet increasing demand for cardiovascular care in the region by expanding the size of our facilities. By increasing the size of our facilities, we expect to be able to:
Expand Access to World-class Treatment
To meet increasing demand for cardiovascular care in the region by expanding the size of our facilities. By increasing the size of our facilities we expect to be able to:
- Accommodate almost three times as many outpatients (~120,000, compared to ~40,000 at present)
- Treat more than three times as many patients in need (~12,000, compared to ~4,000 today)
- Save more than three times as many lives (~11,900 compared to ~3,900 today)
Triple the Number of Training Graduates
- Saving lives is not only about increasing the capacity of our facilities; we also need qualified staff to provide care both at the new Aswan Heart Centre and more broadly throughout the region. Therefore, we have a goal to expand our training program to train healthcare professionals and scientists annually, 1,750 compared to 550 currently.
Develop an Advance Scientific Research Centre
- We aspire to become a centre for innovation and heart-related medical research, with the objective of reducing the prevalence of cardiovascular disease in some of the poorest areas of Africa by developing advanced treatments for complex diseases. Research centre will cover among others congenital heart disease, precision medicine topic and diseases specific to the developing world (e.g. rheumatic diseases). This research will benefit from exposure to the large number of cases we expect to treat (~ 9,500), covering cardiovascular diseases specific to the developing world as well (e.g., rheumatic diseases).
- We also plan to create a broader hub for talented scientists and doctors by building the convention centre to host global medical conferences.
